Five insights from the Global Burden of Disease Study 2019

Carregando...
Imagem de Miniatura
Citações na Scopus
348
Tipo de produção
article
Data de publicação
2020
Título da Revista
ISSN da Revista
Título do Volume
Editora
ELSEVIER SCIENCE INC
Autores
ABBAFATI, Cristiana
ABBAS, Kaja M.
ABBASI, Mohammad
ABBASIFARD, Mitra
ABBASI-KANGEVARI, Mohsen
ABBASTABAR, Hedayat
ABD-ALLAH, Foad
ABDELALIM, Ahmed
ABDOLLAHI, Mohammad
ABDOLLAHPOUR, Ibrahim
Citação
LANCET, v.396, n.10258, p.1135-1159, 2020
Projetos de Pesquisa
Unidades Organizacionais
Fascículo
Resumo
The Global Burden of Diseases, Injuries, and Risk Factors Study (GBD) 2019 provides a rules-based synthesis of the available evidence on levels and trends in health outcomes, a diverse set of risk factors, and health system responses. GBD 2019 covered 204 countries and territories, as well as first administrative level disaggregations for 22 countries, from 1990 to 2019. Because GBD is highly standardised and comprehensive, spanning both fatal and non-fatal outcomes, and uses a mutually exclusive and collectively exhaustive list of hierarchical disease and injury causes, the study provides a powerful basis for detailed and broad insights on global health trends and emerging challenges. GBD 2019 incorporates data from 281 586 sources and provides more than 3.5 billion estimates of health outcome and health system measures of interest for global, national, and subnational policy dialogue. All GBD estimates are publicly available and adhere to the Guidelines on Accurate and Transparent Health Estimate Reporting. From this vast amount of information, five key insights that are important for health, social, and economic development strategies have been distilled. These insights are subject to the many limitations outlined in each of the component GBD capstone papers.
Palavras-chave
Referências
  1. Abbafati C, 2020, LANCET, V396, P1204, DOI 10.1016/S0140-6736(20)30925-9
  2. Afshin A, 2017, NEW ENGL J MED, V377, P13, DOI 10.1056/NEJMoa1614362
  3. [Anonymous], 2018, PRES SIGN EX ORD NAT
  4. Bricker D., 2019, EMPTY PLANET SHOCK G
  5. Cottingham MD, 2014, CTS-CLIN TRANSL SCI, V7, P297, DOI 10.1111/cts.12163
  6. Dieleman JL, 2020, JAMA-J AM MED ASSOC, V323, P863, DOI 10.1001/jama.2020.0734
  7. Fisher JA, 2015, SOC SCI MED, V131, P322, DOI 10.1016/j.socscimed.2014.08.023
  8. Graetz N, 2020, NATURE, V577, P235, DOI 10.1038/s41586-019-1872-1
  9. Institute for Health Metrics and Evaluation, 2019, FIN GLOB HLTH 2018 C
  10. Komatsu R, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-109
  11. Lee C., 2018, PARENTS CHILDREN 5 G
  12. Long G., 2017, BIOPHARMACEUTICAL PI
  13. Lopez AD, 2019, INT J EPIDEMIOL, V48, P1815, DOI 10.1093/ije/dyz143
  14. Lozano R, 2020, LANCET, V396, P1250, DOI 10.1016/S0140-6736(20)30750-9
  15. Lozano R, 2018, LANCET, V392, P2091, DOI [10.1016/S0140-6736(18)32281-5, 10.1016/s0140-6736(18)32281-5]
  16. Maximova Katerina, 2019, CMAJ Open, V7, pE745, DOI 10.9778/cmajo.20190049
  17. Murray CJL, 2020, LANCET, V396, P1223, DOI 10.1016/S0140-6736(20)30752-2
  18. Murray CJL, 2018, LANCET, V392, P1995, DOI 10.1016/s0140-6736(18)32278-5
  19. Murray CJL, 2014, LANCET, V384, P1005, DOI 10.1016/S0140-6736(14)60844-8
  20. National Institutes of Health, 2019, EST FUND VAR RES CON
  21. Tho NH, 2016, INT SOC DESIGN CONF, P259, DOI 10.1109/ISOCC.2016.7799776
  22. Nugent R, 2018, LANCET, V391, P2029, DOI 10.1016/S0140-6736(18)30667-6
  23. Pineda E, 2018, OBESITY FACTS, V11, P360, DOI 10.1159/000492115
  24. SweeHock S, 2016, POPULATION POLICIES AND PROGRAMMES IN SINGAPORE, 2ND EDITION, P1
  25. UN Millennium Project, 2005, INV DEV PRACT PLAN A
  26. United Nations General Assembly, 2018, POL DECL 3 HIGHL M G
  27. Vollset SE, 2020, LANCET, V396, P1285, DOI 10.1016/S0140-6736(20)30677-2
  28. Wang HD, 2020, LANCET, V396, P1160, DOI 10.1016/S0140-6736(20)30977-6
  29. WHO, 2003, WHO FRAM CONV TOB CO
  30. World Health Organization, 2018, NONC DIS
  31. Yach D, 2005, BMJ-BRIT MED J, V330, P898, DOI 10.1136/bmj.330.7496.898